Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China
· Delayed Price · Currency is CNY 3.350
+0.030 (0.90%)
At close: Mar 10, 2026
SHE:002390 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 962.05 | 1,016 | 805.98 | 899.18 | 624.65 | 1,776 | Upgrade
|
| Cash & Short-Term Investments | 962.05 | 1,016 | 805.98 | 899.18 | 624.65 | 1,776 | Upgrade
|
| Cash Growth | 27.88% | 26.00% | -10.37% | 43.95% | -64.84% | 43.76% | Upgrade
|
| Accounts Receivable | 2,587 | 2,691 | 3,036 | 3,091 | 3,082 | 2,666 | Upgrade
|
| Other Receivables | 321.23 | 320.24 | 324.63 | 448.8 | 600.56 | 542.24 | Upgrade
|
| Receivables | 2,908 | 3,012 | 3,361 | 3,540 | 3,682 | 3,209 | Upgrade
|
| Inventory | 928.24 | 1,060 | 1,001 | 1,033 | 935.71 | 843.39 | Upgrade
|
| Prepaid Expenses | - | 0.02 | 0.03 | 0.02 | 0.02 | 0 | Upgrade
|
| Other Current Assets | 132.74 | 164.39 | 243.61 | 334.34 | 333.72 | 262.83 | Upgrade
|
| Total Current Assets | 4,931 | 5,252 | 5,412 | 5,806 | 5,576 | 6,091 | Upgrade
|
| Property, Plant & Equipment | 2,339 | 2,426 | 2,518 | 2,672 | 2,706 | 2,323 | Upgrade
|
| Long-Term Investments | 327.47 | 337.47 | 340.47 | 343.84 | 347.41 | 223.03 | Upgrade
|
| Goodwill | 603.75 | 603.75 | 603.75 | 607.35 | 607.35 | 605.54 | Upgrade
|
| Other Intangible Assets | 180.04 | 189.54 | 180.18 | 204.37 | 217.65 | 219.56 | Upgrade
|
| Long-Term Deferred Tax Assets | 81.5 | 81.87 | 74.14 | 62.81 | 55.61 | 46.51 | Upgrade
|
| Long-Term Deferred Charges | 61.56 | 69.3 | 81.84 | 97.21 | 118.36 | 153.19 | Upgrade
|
| Other Long-Term Assets | 67.39 | 68.57 | 35 | - | - | - | Upgrade
|
| Total Assets | 8,592 | 9,028 | 9,245 | 9,794 | 9,629 | 9,662 | Upgrade
|
| Accounts Payable | 713.79 | 927.97 | 903.15 | 977.24 | 993.43 | 788.57 | Upgrade
|
| Accrued Expenses | 13.79 | 37.15 | 35.27 | 32.99 | 40.93 | 34.23 | Upgrade
|
| Short-Term Debt | 306.96 | 603.54 | 809.86 | 1,368 | 1,390 | 3,410 | Upgrade
|
| Current Portion of Leases | 3.9 | 3 | 4.4 | 2.51 | - | - | Upgrade
|
| Current Income Taxes Payable | 24.96 | 7.6 | 21.09 | 17.21 | 17.79 | 16.46 | Upgrade
|
| Current Unearned Revenue | 24.33 | 25.94 | 27.98 | 33.24 | 55.44 | 39.62 | Upgrade
|
| Other Current Liabilities | 291.74 | 201.68 | 256.82 | 255.56 | 256.6 | 181.45 | Upgrade
|
| Total Current Liabilities | 1,379 | 1,807 | 2,059 | 2,687 | 2,755 | 4,470 | Upgrade
|
| Long-Term Debt | 195.8 | 160 | - | - | - | - | Upgrade
|
| Long-Term Leases | 17.97 | 21 | 21.12 | 22.02 | 24.81 | - | Upgrade
|
| Long-Term Unearned Revenue | 23.89 | 19.52 | 22.04 | 18.89 | 20.38 | 22.88 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.56 | 0.73 | 0.84 | 0.56 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.28 | 0.29 | 0.31 | 0.32 | 0.34 | 0.35 | Upgrade
|
| Total Liabilities | 1,618 | 2,008 | 2,103 | 2,729 | 2,800 | 4,494 | Upgrade
|
| Common Stock | 1,944 | 1,944 | 1,944 | 1,944 | 2,027 | 1,667 | Upgrade
|
| Additional Paid-In Capital | 4,403 | 4,403 | 4,403 | 4,402 | 4,693 | 3,624 | Upgrade
|
| Retained Earnings | 601.97 | 563.43 | 633.34 | 462.74 | 354.99 | 82.17 | Upgrade
|
| Treasury Stock | -199.93 | -199.93 | -127.49 | - | -455.38 | -455.38 | Upgrade
|
| Total Common Equity | 6,749 | 6,710 | 6,852 | 6,808 | 6,620 | 4,918 | Upgrade
|
| Minority Interest | 224.9 | 309.87 | 289.69 | 256.55 | 208.74 | 250.16 | Upgrade
|
| Shareholders' Equity | 6,974 | 7,020 | 7,142 | 7,065 | 6,829 | 5,169 | Upgrade
|
| Total Liabilities & Equity | 8,592 | 9,028 | 9,245 | 9,794 | 9,629 | 9,662 | Upgrade
|
| Total Debt | 524.63 | 787.55 | 835.38 | 1,393 | 1,415 | 3,410 | Upgrade
|
| Net Cash (Debt) | 437.42 | 227.97 | -29.4 | -493.42 | -790.6 | -1,634 | Upgrade
|
| Net Cash Per Share | 0.22 | 0.11 | -0.02 | -0.26 | -0.43 | -1.04 | Upgrade
|
| Filing Date Shares Outstanding | 1,896 | 1,896 | 1,907 | 1,944 | 1,944 | 1,584 | Upgrade
|
| Total Common Shares Outstanding | 1,896 | 1,896 | 1,907 | 1,944 | 1,944 | 1,584 | Upgrade
|
| Working Capital | 3,552 | 3,445 | 3,353 | 3,119 | 2,822 | 1,621 | Upgrade
|
| Book Value Per Share | 3.56 | 3.54 | 3.59 | 3.50 | 3.41 | 3.11 | Upgrade
|
| Tangible Book Value | 5,965 | 5,917 | 6,068 | 5,997 | 5,795 | 4,093 | Upgrade
|
| Tangible Book Value Per Share | 3.15 | 3.12 | 3.18 | 3.08 | 2.98 | 2.58 | Upgrade
|
| Buildings | - | 2,517 | 2,516 | 2,578 | 2,396 | 1,905 | Upgrade
|
| Machinery | - | 1,716 | 1,722 | 1,697 | 1,641 | 1,550 | Upgrade
|
| Construction In Progress | - | 145.02 | 58.06 | 24.98 | 92.38 | 122.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.